A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

455

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Asthma
Interventions
DRUG

Vapendavir

Vapendavir 264 mg twice daily

DRUG

Vapendavir

Vapendavir 528 mg twice daily

DRUG

Placebo

Placebo twice daily

Trial Locations (62)

1202

Biota Investigational site, Sofia

1407

Biota Investigational site, Sofia

1606

Biota Investigational site, Sofia

1618

Biota Investigational site, Sofia

6000

Biota Investigational site, Stara Zagora

7002

Biota Investigational site, Rousse

11570

Biota Investigational site, Rockville Centre

18200

Biota Investigational site, Prague

21236

Biota Investigational site, Baltimore

27601

Biota Investigational site, Mělník

27607

Biota Investigational site, Raleigh

32308

Biota Investigational site, Tallahassee

32765

Biota Investigational site, Oviedo

33016

Biota Investigational site, Hialeah

33157

Biota Investigation site, Palmetto Bay

33722

Biota Investigational site, Rokycany

34653

Biota Investigational site, New Port Richey

35209

Biota Investigational site, Birmingham

37701

Biota Investigational site, Jindřichův Hradec

41002

Biota Investigational site, Lovosice

43617

Biota Investigational site, Toledo

44310

Biota Investigational site, Middleburg

53228

Biota Investigational site, Greenfield

58103

Biota Investigational site, Fargo

63141

Biota Investigational site, St Louis

68123

Biota Investigational site, Bellevue

69733

Biota Investigational site, Kyjov

73120

Biota Investigation site, Oklahoma City

77055

Biota Investigational site, Houston

80112

Biota Investigational site, Centennial

80230

Biota Investigational site, Denver

83301

Biota Investigational site, Twin Falls

86001

Biota Investigational site, Flagstaff

87102

Biota Investigational site, Albuquerque

89146

Biota investigational site, Las Vegas

90025

Biota Investigational site, Los Angeles

92868

Biota Investigational site, Orange

93301

Biota Investigational site, Bakersfield

95117

Biota Investigational Site, San Jose

95207

Biota Investigational site, Stockton

97202

Biota Investigational site, Portland

97504

Biota Investigational site, Medford

98115

Biota Investigational site, Seattle

200446

Biota Investigational site, Craiova

500112

Biota Investigational site, Brasov

547530

Biota Investigational site, Mures

550360

Biota Investigational site, Sibiu

07712

Biota Investigational site, Ocean City

02886

Biota Investigational site, Warwick

0102

Biota Investigational site, Tbilisi

0159

Biota Investigational site, Tbilisi

0186

Biota Investigational site, Tbilisi

15-044

Biota Investigational site, Bialystok

25-734

Biota Investigational site, Kielce

31-023

Biota Investigational site, Krakow

90-153

Biota Investigational site, Lodz

20-552

Biota Investigational site, Lublin

96-100

Biota Investigational site, Skierniewice

01-868

Biota Investigational site, Warsaw

50-044

Biota Investigational site, Wroclaw

51-162

Biota Investigational site, Wroclaw

020671

Biota Investigational site, Bucharest

Sponsors
All Listed Sponsors
lead

Biota Pharmaceuticals, Inc.

INDUSTRY